SCHEMBL23916650

SCHEMBL23916650

BC(C)(C)n1cc(-c2ccc3cnc(N/C(=C/C)c4ccnc(N5CCN(C)CC5)c4)cc3c2)cn1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 20/20 0.64
WNT1 P04628 16/20 0.64
GSK3B P49841 14/20 0.64
CLK2 P49760 8/20 0.64
CLK3 P49761 8/20 0.64
DYRK3 O43781 1/20 0.64
CSNK1E P49674 1/20 0.64
CLK1 P49759 1/20 0.64
CDK5 Q00535 1/20 0.64
CDK5R1 Q15078 1/20 0.64
DYRK2 Q92630 1/20 0.64
CLK4 Q9HAZ1 1/20 0.64
DYRK4 Q9NR20 1/20 0.64
DYRK1B Q9Y463 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19540252 0.84 DYRK1A (0.81) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL23916364 0.81 DYRK1A (0.80) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL23048927 0.81 DYRK1A (0.82) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL23916866 0.80 DYRK1A (0.80) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL23916581 0.79 DYRK1A (0.62) DYRK1AWNT1GSK3BCLK2CLK3
Cirtuvivint SCHEMBL19516414 0.78 DYRK1A (1.00) DYRK1AWNT1GSK3BCLK2CLK3
Cirtuvivint SCHEMBL30675394 0.78 DYRK1A (1.00) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL19540369 0.76 DYRK1A (0.69) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL19547064 0.76 DYRK1A (0.81) DYRK1AWNT1GSK3BCLK2CLK3
Cirtuvivint SCHEMBL19516359 0.76 DYRK1A (0.90) DYRK1AWNT1GSK3BCLK2CLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892276-A1 ISOQUINOLIN-3-YL CARBOXAMIDES AS WNT INHIBITORS BioSplice Therapeutics, Inc. (US) 2021-10-13 EP disclosed